1. Home
  2. MIRM vs SHAK Comparison

MIRM vs SHAK Comparison

Compare MIRM & SHAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$91.35

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Logo Shake Shack Inc.

SHAK

Shake Shack Inc.

HOLD

Current Price

$96.15

Market Cap

3.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MIRM
SHAK
Founded
2018
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.2B
3.6B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
MIRM
SHAK
Price
$91.35
$96.15
Analyst Decision
Strong Buy
Buy
Analyst Count
11
21
Target Price
$97.55
$115.05
AVG Volume (30 Days)
836.6K
1.6M
Earning Date
02-25-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
425.42
EPS
N/A
1.02
Revenue
$471,794,000.00
$1,373,459,000.00
Revenue This Year
$54.25
$18.23
Revenue Next Year
$21.09
$13.50
P/E Ratio
N/A
$95.09
Revenue Growth
53.66
13.49
52 Week Low
$36.88
$72.93
52 Week High
$93.70
$144.65

Technical Indicators

Market Signals
Indicator
MIRM
SHAK
Relative Strength Index (RSI) 71.95 62.26
Support Level $85.98 $88.24
Resistance Level $93.70 $102.96
Average True Range (ATR) 3.83 4.00
MACD 0.95 1.30
Stochastic Oscillator 87.40 71.58

Price Performance

Historical Comparison
MIRM
SHAK

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About SHAK Shake Shack Inc.

Shake Shack Inc is a roadside burger stand. It serves a classic American menu of premium burgers, hot dogs, crispy chicken, frozen custard, crinkle-cut fries, shakes, beer, wine and more. The company's burgers are made with a whole-muscle blend of all-natural, hormone and antibiotic-free Angus beef, ground fresh daily, cooked to order, and served on a non-genetically modified organism (GMO) potato bun. Its menu focuses on food and beverages, crafted from a range of classic American foods. The company serves draft Root Beer, seasonal freshly-squeezed lemonade, organic fresh brewed iced tea, cold brew coffee, organic apple juice, and Shack20 bottled water.

Share on Social Networks: